The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) closed at $9.36 in the last session, up 3.60% from day before closing price of $9.04. In other words, the price has increased by $3.60 from its previous closing price. On the day, 2.2 million shares were traded. SNDX stock price reached its highest trading level at $9.561 during the session, while it also had its lowest trading level at $8.92.
Ratios:
We take a closer look at SNDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.75 and its Current Ratio is at 5.80. In the meantime, Its Debt-to-Equity ratio is 1.61 whereas as Long-Term Debt/Eq ratio is at 1.54.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $37.
On June 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $37.
Scotiabank Downgraded its Sector Outperform to Sector Perform on January 31, 2024, whereas the target price for the stock was revised from $36 to $23.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 16 ’25 when Botwood Nicholas A.J. bought 11,765 shares for $8.99 per share. The transaction valued at 105,826 led to the insider holds 35,165 shares of the business.
Huber Martin H. Jr. bought 5,000 shares of SNDX for $44,950 on May 19 ’25. The Director now owns 79,000 shares after completing the transaction at $8.99 per share. On May 19 ’25, another insider, Katkin Keith, who serves as the Director of the company, bought 10,000 shares for $9.11 each. As a result, the insider paid 91,120 and bolstered with 100,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 805833856 and an Enterprise Value of 635151360. For the stock, the TTM Price-to-Sale (P/S) ratio is 18.43 while its Price-to-Book (P/B) ratio in mrq is 3.75. Its current Enterprise Value per Revenue stands at 14.527 whereas that against EBITDA is -1.848.
Stock Price History:
The Beta on a monthly basis for SNDX is 0.70, which has changed by -0.5467086 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, SNDX has reached a high of $25.07, while it has fallen to a 52-week low of $8.58. The 50-Day Moving Average of the stock is -14.13%, while the 200-Day Moving Average is calculated to be -34.99%.
Shares Statistics:
According to the various share statistics, SNDX traded on average about 2.30M shares per day over the past 3-months and 2268980 shares per day over the past 10 days. A total of 86.05M shares are outstanding, with a floating share count of 82.47M. Insiders hold about 4.16% of the company’s shares, while institutions hold 115.59% stake in the company. Shares short for SNDX as of 1749772800 were 22003021 with a Short Ratio of 9.58, compared to 1747267200 on 21733924. Therefore, it implies a Short% of Shares Outstanding of 22003021 and a Short% of Float of 28.88.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
